Cart
sales@molnova.com
CYM2503
CAS No. 1308833-36-4
CYM2503( —— )
Catalog No. M23466 CAS No. 1308833-36-4
CYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 112 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 355 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | 682 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCYM2503
-
NoteResearch use only, not for human use.
-
Brief DescriptionCYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro.
-
DescriptionCYM2503 is a positive allosteric modulator (PAM) of the GAL2 receptor that potentiates galanin-induced IP1 production in vitro. It has no affinity for the orthosteric galanin binding site of the receptor (as measured by its inability to displace iodinated galanin, or to induce IP1 accumulation on its own).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
RecptorGAL2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1308833-36-4
-
Formula Weight777.96
-
Molecular FormulaC45H55N5O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(N[C@H](C(N[C@@H](CCCCNC(OC(C)(C)C)=O)C(NC1=CC=C(C(C)=C2)C(NC2=O)=C1)=O)=O)CC3CCCCC3)OCC4C5=CC=CC=C5C6=CC=CC=C46
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lu X , Roberts R , Xia R , et al. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models[J]. Proc Natl Acad Sci U S A, 2010, 107(34):15229-15234.
molnova catalog
related products
-
AC-263093
AC-263093 is an NPFFR2 agonist with anxiolytic activity that increases c-Fos protein expression in the paraventricular nucleus of the hypothalamus.
-
Galnon TFA
Galnon is a novel non-peptide galanin receptor agonist (GAL1 and GAL2 with Ki of 11.7 and 34.1 μM respectively).
-
Galnon
Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue propertiesGalnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury.
